Mediastinal bleeding after cardiopulmonary bypass in pediatric patients

Annals of Thoracic Surgery

Volumn 62, Issue 6, 1996, Pages 1955-1960

  Guay, Joanne ^a   Rivard, Georges Étienne ^a  

^a MAISONNEUVE ROSEMONT HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOCAPROIC ACID; APROTININ; DESMOPRESSIN;

BLEEDING; BLEEDING DISORDER; BLOOD TRANSFUSION; CARDIOPULMONARY BYPASS; CHILD; HEART DISEASE; HUMAN; MEDIASTINUM; PRIORITY JOURNAL; REVIEW; THROMBOCYTOPENIA;

EID: 0030550359     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-4975(96)00938-1     Document Type: Article

References (30)

1. 1. Manno CS, Hedberg KW, Kim HC, et al. Comparison of the hemostatic effects of fresh whole blood, stored whole blood, and components after open heart surgery in children. Blood 1991;77:930-6.
2. 2. Boldt J, Knothe C, Zickmann B, Wege N, Dapper F, Hempelmann G. Aprotinin in pediatric cardiac operations: platelet function, blood loss, and use of homologous blood. Ann Thorac Surg 1993;55:1460-6.
3. 3. Andrew M, Paes B, Milner R, et al. Development of the human coagulation system in the full-term infant. Blood 1987;70:165-72.
4. 4. Kern FH, Morana NJ, Sears JJ, Hickey PR. Coagulation defects in neonates during cardiopulmonary bypass. Ann Thorac Surg 1992;54:541-6.
5. 5. Vieira A, Berry L, Ofosu F, Andrew M. Heparin sensitivity and resistance in the neonate: an explanation. Thromb Res 1991;63:85-98.
6. 6. Hashimoto K, Yamagishi M, Sasaki T, Nakano M, Kurosawa H. Heparin and antithrombin III levels during cardiopulmonary bypass: correlation with subclinical plasma coagulation. Ann Thorac Surg 1994;58:799-805.
7. 7. Gravlee GP, Rogers AT, Dudas LM, et al. Heparin management protocol for cardiopulmonary bypass influences postoperative heparin rebound but not bleeding. Anesthesiology 1992;76:393-401.
8. 8. Gross S, Keefer V, Liebman J. The platelets in cyanotic congenital heart disease. Pediatrics 1968;42:651-8.
9. 9. Maurer HM, McCue CM, Caul J, Still WJS. Impairment in platelet aggregation in congenital heart disease. Blood 1972; 40:207-16.
10. 10. Gill JC, Wilson AD, Endres-Brooks J, Montgomery RR. Loss of the largest von Willebrand factor multimers from the plasma of patients with congenital cardiac defects. Blood 1986;67:758-61.
11. 11. Komp DM, Sparrow AW. Polycythemia in cyanotic heart disease - a study of altered coagulation. J Pediatr 1970;76: 231-6.
12. 12. Wedemeyer AL, Castañeda AR, Edson JR, Krivit W. Serial coagulation studies in patients undergoing Mustard procedure. Ann Thorac Surg 1973;15:120-7.
13. 13. Seear MD, Wesworth LD, Rogers PC, Sheps S, Ashmore PG. The effect of desmopressin acetate (DDAVP) on postoperative blood loss after cardiac operations in children. J Thorac Cardiovasc Surg 1989;98:217-9.
14. 14. Dietrich W, Mössinger H, Spannagl M, et al. Hemostatic activation during cardiopulmonary bypass with different aprotinin dosages in pediatric patients having cardiac operations. J Thorac Cardiovasc Surg 1993;105:712-20.
15. 15. Greeley WJ, Bushman GA, Kong DL, Oldham HN, Peterson MB. Effects of cardiopulmonary bypass on eicosanoid metabolism during pediatric cardiovascular surgery. J Thorac Cardiovasc Surg 1988;95:842-9.
16. 16. Harker LA. Bleeding after cardiopulmonary bypass [Editorial]. N Engl J Med 1986;314:1446-8.
17. 17. Cohen JA, Bethea HL, Rush WJ. Heparin kinetics during paediatric open-heart operations. Perfusion 1986;1:271-5.
18. 18. Martin P, Horkay F, Rajah SM, Walker DR. Monitoring of coagulation status using thromboelastography during paediatric open heart surgery. Int J Clin Monit Comput 1991;8: 183-7.
19. 19. Reynolds LM, Nicolson SC, Jobes DR, et al. Desmopressin does not decrease bleeding after cardiac operation in young children. J Thorac Cardiovasc Surg 1993;106:954-8.
20. 20. Mac Clure PD, Izsak J. The use of epsilon-aminocaproic acid to reduce bleeding during cardiac bypass in children with congenital heart disease. Anesthesiology 1974;40:604-8.
21. 21. Reichert C, Zonis Z, Seear M, Sett S. Effect of tranexamic acid on blood loss following cardiac surgery in children [Abstract]. Can J Anaesth 1995;42:A55.
22. 22. Dietrich W, Mössinger HJ. Invited letter concerning: Aprotinin use in pediatric cardiac operations. Reply to the editor. J Thorac Cardiovasc Surg 1993;105:758-9.
23. 23. Urban AE, Popov-Cenic S, Noë G, Kulzer R. Aprotinin in open-heart surgery of infants and children using the heart-lung machine. Clin Ther 1984;6:425-33.
24. 24. Hazan E, Pasaoglu I, Demircin M, Bozer AY. The effect of aprotinin (Trasylol) on postoperative bleeding in cyanotic congenital heart disease. Turkish J Pediatr 1991;33:99-110.
25. 25. Boldt J, Knothe C, Zickmann B, Wege N, Dapper F, Hempelmann G. Comparison of two aprotinin dosage regimens in pediatric patients having cardiac operations. Influence on platelet function and blood loss. J Thorac Cardiovasc Surg 1993;105:705-11.
26. 26. Boldt J, Zickmann B, Schindler E, Welters A, Dapper F, Hempelmann G. Influence of aprotinin on the thrombomodulin/protein C system in pediatric cardiac operations. J Thorac Cardiovasc Surg 1994;107:1215-21.
27. 27. Herynkopf F, Lucchese F, Pereira E, Kalil R, Prates P, Nesralla IA. Aprotinin in children undergoing correction of congenital heart defects. A double-blind pilot study. J Thorac Cardiovasc Surg 1994;108:517-21.
28. 28. Fritz H, Wunderer G. Biochemistry and applications of aprotinin, the kallikrein inhibitor from bovine organs. Arzneimittel-Forschung 1983;33:479-94.
29. 29. Murray DJ, Olson J, Strauss R, Tinker JH. Coagulation changes during packed red cell replacement of major blood loss. Anesthesiology 1988;69:839-45.
30. 30. Lake CL. Postoperative complications. In: Lake CL, ed. Pediatric cardiac anesthesia. 2nd ed. Norwalk, CT: Appleton and Lange, 1993:465-83.